BEIJING WANTAI BIOLOGICAL PHARMACYBEIJING WANTAI BIOLOGICAL PHARMACYBEIJING WANTAI BIOLOGICAL PHARMACY

BEIJING WANTAI BIOLOGICAL PHARMACY

No trades
See on Supercharts

603392 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and equipment, and vaccines. It operates through the In Vitro Diagnostic Reagents and Vaccines segments. The In Vitro Diagnostic Reagents segment covers human immunodeficiency virus and viral hepatitis reagents, and automatic tubular chemiluminescence immunoassay systems. The Vaccines segment offers recombinant hepatitis E, human papillomavirus, and freeze-dried live attenuated varicella vaccines. The company was founded on April 24, 1991 and is headquartered in Beijing, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
603392 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company